103 related articles for article (PubMed ID: 19131130)
1. HIV-associated vascular diseases: structural and functional changes, clinical implications.
Monsuez JJ; Charniot JC; Escaut L; Teicher E; Wyplosz B; Couzigou C; Vignat N; Vittecoq D
Int J Cardiol; 2009 Apr; 133(3):293-306. PubMed ID: 19131130
[TBL] [Abstract][Full Text] [Related]
2. [HIV infection, antiretroviral therapy, and endothelium].
Hürlimann D; Weber R; Enseleit F; Lüscher TF
Herz; 2005 Sep; 30(6):472-80. PubMed ID: 16170677
[TBL] [Abstract][Full Text] [Related]
3. Molecular biological assessment methods and understanding the course of the HIV infection.
Katzenstein TL
APMIS Suppl; 2003; (114):1-37. PubMed ID: 14626050
[TBL] [Abstract][Full Text] [Related]
4. Cardiovascular complications and atherosclerotic manifestations in the HIV-infected population: type, incidence and associated risk factors.
Boccara F
AIDS; 2008 Sep; 22 Suppl 3():S19-26. PubMed ID: 18845918
[TBL] [Abstract][Full Text] [Related]
5. Cardiovascular disease in HIV infection.
Sudano I; Spieker LE; Noll G; Corti R; Weber R; Lüscher TF
Am Heart J; 2006 Jun; 151(6):1147-55. PubMed ID: 16781213
[TBL] [Abstract][Full Text] [Related]
6. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
Van Vaerenbergh K
Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
[TBL] [Abstract][Full Text] [Related]
7. [Atherosclerosis in HIV-positive patients].
Neumann T; Miller M; Esser S; Gerken G; Erbel R
Z Kardiol; 2002 Nov; 91(11):879-88. PubMed ID: 12442190
[TBL] [Abstract][Full Text] [Related]
8. [Prevention of wasting and opportunistic infections in HIV-infected patients in West Africa: a realistic and necessary strategy before antiretroviral treatment].
Ledru é ; Sanou PT; Dembele M; Dahourou H; Zoubga A; Durand G
Sante; 1999; 9(5):293-300. PubMed ID: 10657773
[TBL] [Abstract][Full Text] [Related]
9. Clinical characteristics and mid-term prognosis of acute coronary syndrome in HIV-infected patients on antiretroviral therapy.
Boccara F; Ederhy S; Janower S; Benyounes N; Odi G; Cohen A
HIV Med; 2005 Jul; 6(4):240-4. PubMed ID: 16011528
[TBL] [Abstract][Full Text] [Related]
10. Highly active antiretroviral therapy-associated metabolic syndrome: pathogenesis and cardiovascular risk.
Barbaro G
Am J Ther; 2006; 13(3):248-60. PubMed ID: 16772767
[TBL] [Abstract][Full Text] [Related]
11. Therapy insight: Body-shape changes and metabolic complications associated with HIV and highly active antiretroviral therapy.
Falutz J
Nat Clin Pract Endocrinol Metab; 2007 Sep; 3(9):651-61. PubMed ID: 17710086
[TBL] [Abstract][Full Text] [Related]
12. AIDS-related lipodystrophy/insulin resistance syndrome.
Kino T; Mirani M; Alesci S; Chrousos GP
Horm Metab Res; 2003 Mar; 35(3):129-36. PubMed ID: 12734771
[TBL] [Abstract][Full Text] [Related]
13. Endothelial function in HIV-infected patients with low or mild cardiovascular risk.
Blanco JJ; García IS; Cerezo JG; de Rivera JM; Anaya PM; Raya PG; García JG; López JR; Hernández FJ; Rodríguez JJ
J Antimicrob Chemother; 2006 Jul; 58(1):133-9. PubMed ID: 16702174
[TBL] [Abstract][Full Text] [Related]
14. Update on cardiovascular complications in HIV infection.
Currier JS
Top HIV Med; 2009; 17(3):98-103. PubMed ID: 19675367
[TBL] [Abstract][Full Text] [Related]
15. Metabolic disorders and cardiovascular risk in HIV-infected patients treated with antiretroviral agents.
Fantoni M; Del Borgo C; Autore C; Barbaro G
Ital Heart J; 2002 May; 3(5):294-9. PubMed ID: 12066561
[TBL] [Abstract][Full Text] [Related]
16. Dyslipidaemia associated with antiretroviral therapy in HIV-infected patients.
Calza L; Manfredi R; Chiodo F
J Antimicrob Chemother; 2004 Jan; 53(1):10-4. PubMed ID: 14645323
[TBL] [Abstract][Full Text] [Related]
17. Vascular injury, hypertension and coronary artery disease in human immunodeficiency virus infection.
Barbaro G
Clin Ter; 2008; 159(1):51-5. PubMed ID: 18399263
[TBL] [Abstract][Full Text] [Related]
18. Cardiovascular disease prevention and treatment in patients with human immunodeficiency virus.
Magen E; Elbirt D; Sthoeger Z
Isr Med Assoc J; 2005 Apr; 7(4):252-6. PubMed ID: 15847207
[TBL] [Abstract][Full Text] [Related]
19. Risks of cardiovascular disease in patients receiving antiretroviral therapy for HIV infection: implications for treatment.
Steinhart CR; Emons MF
AIDS Read; 2004 Feb; 14(2):86-90, 93-5. PubMed ID: 14997864
[TBL] [Abstract][Full Text] [Related]
20. [Metabolic abnormalities, lipodystrophy and cardiovascular risk in HIV-infected patients].
Leclercq P; Blanc M
Rev Prat; 2006 May; 56(9):987-94. PubMed ID: 16775979
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]